[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351965-105":59,"doc-detail-351965-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pandemic-era-increases-in-late-stage-pediatric-cancer-diagnoses-2020-2022","Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022","","COVID-19 pandemic disruptions may have shifted pediatric cancer detection in the United States. Using the National Childhood Cancer Registry, the study compared observed incidence among ages 0-17 in 2020-2022 to expected rates based on pre-pandemic trends, reporting 95% credible intervals. Overall incidence matched expectations, but late-stage incidence was higher than expected (10.58 vs 10.19 per 100 000). Results by race/ethnicity and cancer site were assessed, emphasizing restored timely evaluation and maintained diagnostic access during system disruption.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pandemic-era-increases-in-late-stage-pediatric-cancer-diagnoses-2020-2022/351965/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pandemic-era-increases-in-late-stage-pediatric-cancer-diagnoses-2020-2022/351965.png","ImageObject",300,407,{"name":92,"@type":93},"Well Done","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What population and time period were analyzed for pediatric cancer incidence?","Question",{"text":113,"@type":114},"Incidence was evaluated for individuals aged 0-17 during 2020-2022 and compared with expected rates derived from pre-pandemic trends.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did the pandemic-era overall incidence of pediatric cancer compare with expectations?",{"text":118,"@type":114},"Overall pediatric cancer incidence during the COVID-19 pandemic matched expectations, with observed and expected rates being very similar (17.44 vs 17.39 per 100 000).",{"name":120,"@type":111,"acceptedAnswer":121},"What changed specifically for late-stage pediatric cancer diagnoses?",{"text":122,"@type":114},"Late-stage incidence was significantly higher than expected during 2020-2022 (10.58 vs 10.19 per 100 000), indicating increased late diagnoses despite overall incidence stability.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351965,1790212027,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":52,"preview_page_count":19,"preview_urls":145},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","JNCI Cancer Spectrum, 2026, 10(4), pkag067  \n[https://doi.org/10.1093/jncics/pkag067](https://doi.org/10.1093/jncics/pkag067)  \nAdvance Access Publication Date: June 22, 2026  \nBrief Communications  \nPandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022  \nTodd Burus , PhD1, 2 and Jason Semprini , PhD, MPP􀀃 ,3  \n1Markey Cancer Center, University of Kentucky, Lexington, KY, United States  \n2Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, KY, United States 3Department of Public Health, Des Moines University College of Health Sciences, West Des Moines, IA, United States  \n􀀃 Corresponding author: Jason Semprini, PhD, MPP, Department of Public Health, Des Moines University College of Health Sciences, 8025 Grand Ave, West Des Moines, IA 50266, United States ([Jsemprini@dmu.edu](Jsemprini@dmu.edu)) .  \nAbstract  \nCOVID-19 pandemic-related disruptions may have altered pediatric cancer detection in the United States. Using the National Childhood Cancer Registry, we compared observed incidence rates among individuals aged 0-17 years during 2020-2022 with expected rates with 95% credible intervals (CrIs) derived from pre-pandemic trends. Rates were evaluated overall and by race/ethnicity, cancer site, and stage-at-diagnosis. Among 27 996 cancers diagnosed in 2020-2022, total incidence was 17.44 per 100 000, similar to the expected rate of 17.39 (95% CrI ¼ 16.80-17.98) . Annual patterns showed an incidence reduction in 2020, followed by modestly higher-than-expected rates in 2021-2022. Pandemic-era late-stage incidence was significantly higher than expected, however (10.58 vs 10.19 per 100 000). Overall, pediatric cancer incidence during the COVID-19 pandemic matched expectations, but late-stage diagnoses increased, underscoring the need to restore timely evaluation and maintain diagnostic access during health-system disruptions.  \nWhile pediatric COVID-19 mortality was low in the United States, other pandemic-associated impacts on children remain a concern.1 , 2 Building upon prior work documenting changes in pediatric cancer burden during 2020-2021,3 ,4 we aimed to investigate changes in pediatric cancer incidence across the first 3 years of the pandemic. We compared observed pediatric cancer incidence rates for 2020-2022 with expected rates by sociodemographic factors, cancer site, and stage.  \nData for this study were obtained from the National Childhood Cancer Registry (NCCR)—a specialized collection of information on pediatric, adolescent, and young adult cancers that includes 25 states and covers approximately 73% of the US population aged 0-39 years. The NCCR database—part of the National Cancer Institute’s Childhood Cancer Data Initiative—relies on submissions to the North American Association of Central Cancer Registries Cancer in North America dataset and is made available for research purposes through the SEER􀀃 Stat platform. We identified malignant cancer cases among individuals aged 0-17 years using SEER􀀃 Stat version 9.0. Annual case counts for 2005-2022 were stratified by single year of age. We extracted additional information on race/ethnicity (Hispanic, non-Hispanic Black, non-Hispanic White, other non-Hispanic races), cancer site, and stage at diagnosis (early, late, other) . Race and ethnicity were identified according to the SEER Race and origin recode variable.“Other non-Hispanic races” combined nonHispanic American Indian/Alaska Native, Asian or Pacific Islander, and unknown races due to small counts. Cancer sites were identified according to the International Classification of Childhood Cancer, Third Edition (ICCC-3) site groups: leukemias; lymphomas; central nervous system (CNS) tumors; neuroblastomas; retinoblastoma; renal tumors; hepatic tumors; bone  \ntumors; soft tissue sarcomas; germ cell tumors; other epithelial neoplasms and melanomas; and other malignant neoplasms.5 Stage at diagnosis was based on the SEER program’s Summary Stage (2004þ) variable","cbCaiuz2NJqj7niG","https://ap.wps.com/l/cbCaiuz2NJqj7niG","pdf",478753,"English","# Abstract\n## Study comparison framework\n## Data source and case definitions\n## Bayesian age-period-cohort modeling\n## Main incidence findings","[{\"question\":\"What population and time period were analyzed for pediatric cancer incidence?\",\"answer\":\"Incidence was evaluated for individuals aged 0-17 during 2020-2022 and compared with expected rates derived from pre-pandemic trends.\"},{\"question\":\"How did the pandemic-era overall incidence of pediatric cancer compare with expectations?\",\"answer\":\"Overall pediatric cancer incidence during the COVID-19 pandemic matched expectations, with observed and expected rates being very similar (17.44 vs 17.39 per 100 000).\"},{\"question\":\"What changed specifically for late-stage pediatric cancer diagnoses?\",\"answer\":\"Late-stage incidence was significantly higher than expected during 2020-2022 (10.58 vs 10.19 per 100 000), indicating increased late diagnoses despite overall incidence stability.\"}]","Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022 | PDF",1790096629,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1910ac25511f076422e546407b4ab11f.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a1134e7cbd75f8c74b428a1956fe112.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd111fabfa5850727f1b9963565d6d67.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0ff29dd4e3b41f816be15dcad776610.webp",980,1287]